Brief: Sensorion Announces Last Visit In SENS-111 Phase 2 Clinical Trial

Sensorion SA

17/10/2019 06:43

Oct 17 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES THE LAST PATIENT’S LAST VISIT IN
SENS-111
PHASE 2 CLINICAL TRIAL
    * WE REMAIN ON TRACK FOR TOPLINE DATA READOUT IN Q4 2019 -
CEO

Source text for Eikon:  ID:nBw5XrBx6a 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))